Lyon Joseph Douglas sold $176K of CORT
Lyon Joseph Douglas (See Remarks) sold 1,540 shares of CORCEPT THERAPEUTICS INC (CORT) at $114.16 ($0.18M total) on 2026-08-03.
How this was made
The 30-second read
Why it matters
The only new information is the specific sale size, price, and post-transaction holdings; it does not provide new operational or financial guidance.
Market read
Traders may note the insider selling datapoint, but it is unlikely to drive a fundamental repricing without corroborating company-specific news.
What to watch
Check for additional Form 4s around the same period, whether the sale was part of broader planned selling, and compare sale size to typical insider activity.
Background
The article is an SEC Form 4 insider transaction disclosure for Corcept Therapeutics, reported by an officer.
Ticker impact
Corcept Therapeutics Form 4 shows officer Lyon Joseph Douglas sold 1,540 shares at $114.16 on 2026-08-03, totaling $175,806.40.
Likely limited near-term impact; treat as routine insider selling unless follow-on filings or unusual volume emerge.
The filing is primary-source and time-stamped, but it does not include new company fundamentals, guidance, or regulatory/operational developments.
Market effects
No clear sector read-through from a single disclosed insider sale.
None indicated.
None indicated.
Counterpoint
Insider sales can be tax- or diversification-driven and may not signal bearish fundamentals, especially without a stated 10b5-1 plan.
Key entities
- issuerCorcept Therapeutics Inc
Subject of the Form 4 insider transaction disclosure.
- insiderLyon Joseph Douglas
Officer who sold 1,540 shares in an open-market sale.
